Chongqing Lummy Pharmaceutical (300006.SZ) has obtained two drug registration certificates.

Chongqing Lummy Pharmaceutical (300006.SZ) announced that the company has received the "Drug Registration Certificate" for two drugs approved and issued by the National Medical Products Administration: Nicardipine tablets (specification: 5mg) and Ketorolac Tromethamine injection (specification: 1ml: 30mg). The announcement mentioned that Nicardipine tablets are used for the treatment of angina pectoris, while Ketorolac Tromethamine injection is suitable for short-term treatment of moderate to severe acute postoperative pain.